A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

“It slows down gastric emptying, reduces appetite, decreases food intake, so you lose weight,” Azar said. Trizepatide (Zepbound), on the other hand, mimics two different hormones — GLP-1 ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.